Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016
Oct 27, 2016 12:02 pm UTC| Business
BRIDGEWATER, N.J., Oct. 27, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the needs of patients with rare diseases, today announced that it will release its third quarter...
Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016
Oct 27, 2016 12:02 pm UTC| Business
BRIDGEWATER, N.J., Oct. 27, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the needs of patients with rare diseases, today announced that it will release its third quarter...
Pacific Mercantile Bank Provides $6.8 Million in Financing to Hoosier Inc.
Oct 27, 2016 12:02 pm UTC| Business
COSTA MESA, Calif., Oct. 27, 2016 -- Pacific Mercantile Bank (“the Bank”), the wholly owned subsidiary of Pacific Mercantile Bancorp (NASDAQ:PMBC), today announced that it has extended $6.8 million in financing to...
Cara Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016
Oct 27, 2016 12:02 pm UTC| Business
STAMFORD, Conn., Oct. 27, 2016 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Temprano Techvestors Acquires Network Security Group
Oct 27, 2016 12:01 pm UTC| Business
NEWTON, N.C., Oct. 27, 2016 -- Temprano Techvestors, the company dedicated to bringing European software products and services to market in North America, today announced the acquisition of Network Security Group (NSG),...
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
Oct 27, 2016 12:01 pm UTC| Business
WALTHAM, Mass., Oct. 27, 2016 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: Credit Suisse 2016 Healthcare ConferenceMonday,...
CytomX Therapeutics to Announce Third Quarter 2016 Financial Results
Oct 27, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 27, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will announce financial...